# TELEFLEX INC (TFX) — capital_return/buyback_authorization [announced]
Source: SEC API (secapi.ai) · situation sit_75555cfc760f546fc275 · retrieved 2026-08-12T07:26:06.450Z

## Overview
Teleflex Incorporated is a medical device company that manufactures surgical and medical instruments and apparatus.

On August 7, 2026, Teleflex Incorporated entered into an accelerated share repurchase (ASR) program with Truist Bank to repurchase an aggregate of $250 million of the Company's common stock. On August 10, 2026, the Company will make payment of the $250 million repurchase price in exchange for an initial delivery of common stock with an aggregate value of 80% of the repurchase price based on the closing share price on August 6, 2026. The total number of shares to be repurchased will be based on volume-weighted average prices during the term of the ASR Transaction, less a discount and subject to customary adjustments. The ASR Transaction is scheduled to terminate in the fourth quarter of 2026 but may conclude earlier at the election of the Counterparty. The Company will fund the repurchase price with proceeds from the sale of its Original Equipment Manufacturing and Development Services business.

## Terms
- Counterparty: Truist Bank · Deal value: $250.0M · Consideration: cash

## Key dates
- Announced 2026-08-07

## Timeline
- 2026-08-07 · 8-K (0000096943-26-000097): 8-K - TELEFLEX INC — *Teleflex Incorporated is a medical device company that manufactures surgical and medical instruments and apparatus.* On August 7, 2026, Teleflex Incorporated entered into an accelerated share repurchase (ASR) program with Truist Bank to repurchase an aggregate of $250 million of the Company's common stock. On August 10, 2026, the Company will make payment of the $250 million repurchase price in exchange for an initial delivery of common stock with an aggregate value of 80% of the repurchase price based on the closing share price on August 6, 2026. The total number of shares to be repurchased will be based on volume-weighted average prices during the term of the ASR Transaction, less a discount and subject to customary adjustments. The ASR Transaction is scheduled to terminate in the fourth quarter of 2026 but may conclude earlier at the election of the Counterparty. The Company will fund the repurchase price with proceeds from the sale of its Original Equipment Manufacturing and Development Services business.
  https://www.sec.gov/Archives/edgar/data/96943/0000096943-26-000097.txt

## Citations
- 0000096943-26-000097 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000009694326000097